Latest Breaking News On - Pediatric cancer genetic risk program - Page 1 : comparemela.com

Gene therapy trials for sickle cell disease have been showing great promise, even offering hope of a cure. But in early 2021, the trials ground to a halt after reports of blood malignancies in two people in a trial sponsored by bluebird bio.

United statesUnited kingdomAlex liggettVijay sankaranErica esrickDavida williamsEmily hendersonBlood institute cure sickle cellBlood disorders centerNational heartBoston childrenBlood disordersClinical investigationBlood instituteCure sickle cellPediatric cancer genetic risk program